Drug Type Small molecule drug |
Synonyms Islatravir/Lenacapavir Sodium, Lenacapavir/Islatravir, MK 8591D + [2] |
Target |
Mechanism HIV-1 capsid inhibitors(HIV-1 capsid inhibitors), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC39H32ClF10N7O5S2 |
InChIKeyBRYXUCLEHAUSDY-WEWMWRJBSA-N |
CAS Registry2189684-44-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | US | 05 Oct 2021 |